28390176|t|Cucurbitacin B Protects Against Pressure Overload Induced Cardiac Hypertrophy
28390176|a|Lack of effective anti-cardiac hypertrophy drugs creates a major cause for the increasing prevalence of heart failure. In the present study, we determined the anti-hypertrophy and anti-fibrosis potential of a natural plant triterpenoid, Cucurbitacin B both in vitro and in vivo. Aortic banding (AB) was performed to induce cardiac hypertrophy. After 1 week of surgery, mice were receive cucurbitacin B treatment (Gavage, 0.2 mg/kg body weight /2 day). After 4 weeks of AB, cucurbitacin B demonstrated a strong anti-hypertrophy and -fibrosis ability as evidenced by decreased of heart weight, myocardial cell cross-sectional area and interstitial fibrosis, ameliorated of systolic and diastolic abnormalities, normalized in gene expression of hypertrophic and fibrotic markers, reserved microvascular density in pressure overload induced hypertrophic mice. Cucurbitacin B also showed significant hypertrophy inhibitory effect in phenylephrine stimulated cardiomyocytes. The Cucurbitacin B -mediated mitigated cardiac hypertrophy was attributable to the increasing level of autophagy, which was associated with the blockade of Akt / mTOR / FoxO3a signal pathway, validated by SC79, MK2206, and 3-MA, the Akt agonist, inhibitor and autophagy inhibitor in vitro. The overexpression of constitutively active Akt completely abolished the Cucurbitacin B -mediated protection of cardiac hypertrophy in human cardiomyocytes AC16. Collectively, our findings suggest that cucurbitacin B protects against cardiac hypertrophy through increasing the autophagy level in cardiomyocytes, which is associated with the inhibition of Akt / mTOR / FoxO3a signal axis. J. Cell. Biochem. 9999: 1-12, 2017. Â© 2017 Wiley Periodicals, Inc.
28390176	0	14	Cucurbitacin B	T103	UMLS:C0056580
28390176	58	77	Cardiac Hypertrophy	T038	UMLS:C1383860
28390176	96	126	anti-cardiac hypertrophy drugs	T103	UMLS:C1254351
28390176	182	195	heart failure	T038	UMLS:C0018801
28390176	237	253	anti-hypertrophy	T033	UMLS:C0243095
28390176	258	271	anti-fibrosis	T033	UMLS:C0243095
28390176	287	300	natural plant	T204	UMLS:C0032098
28390176	301	313	triterpenoid	T103	UMLS:C1519655
28390176	315	329	Cucurbitacin B	T103	UMLS:C0056580
28390176	357	371	Aortic banding	T058	UMLS:C0185014
28390176	373	375	AB	T058	UMLS:C0185014
28390176	401	420	cardiac hypertrophy	T038	UMLS:C1383860
28390176	438	445	surgery	T058	UMLS:C0543467
28390176	447	451	mice	T204	UMLS:C0025929
28390176	465	479	cucurbitacin B	T103	UMLS:C0056580
28390176	480	489	treatment	T058	UMLS:C0087111
28390176	547	549	AB	T058	UMLS:C0185014
28390176	551	565	cucurbitacin B	T103	UMLS:C0056580
28390176	588	604	anti-hypertrophy	T033	UMLS:C0243095
28390176	609	618	-fibrosis	T033	UMLS:C0243095
28390176	656	661	heart	T017	UMLS:C0018787
28390176	670	685	myocardial cell	T017	UMLS:C0225828
28390176	711	732	interstitial fibrosis	T038	UMLS:C0240035
28390176	762	771	diastolic	T201	UMLS:C0012000
28390176	772	785	abnormalities	T033	UMLS:C0205161
28390176	801	816	gene expression	T038	UMLS:C0017262
28390176	820	832	hypertrophic	T038	UMLS:C0020564
28390176	846	853	markers	T201	UMLS:C0005516
28390176	915	927	hypertrophic	T038	UMLS:C0020564
28390176	928	932	mice	T204	UMLS:C0025929
28390176	934	948	Cucurbitacin B	T103	UMLS:C0056580
28390176	973	984	hypertrophy	T038	UMLS:C0020564
28390176	985	1002	inhibitory effect	T033	UMLS:C0243095
28390176	1006	1019	phenylephrine	T103	UMLS:C0031469
28390176	1031	1045	cardiomyocytes	T017	UMLS:C0225828
28390176	1051	1065	Cucurbitacin B	T103	UMLS:C0056580
28390176	1086	1105	cardiac hypertrophy	T038	UMLS:C1383860
28390176	1150	1159	autophagy	T038	UMLS:C0004391
28390176	1203	1206	Akt	T103	UMLS:C0164786
28390176	1209	1213	mTOR	T103	UMLS:C1453984
28390176	1216	1222	FoxO3a	T103	UMLS:C1506134
28390176	1223	1237	signal pathway	T038	UMLS:C0037080
28390176	1252	1256	SC79	T103	UMLS:C4307495
28390176	1258	1264	MK2206	T103	UMLS:C2933427
28390176	1270	1274	3-MA	T103	UMLS:C0047569
28390176	1280	1283	Akt	T103	UMLS:C0164786
28390176	1284	1291	agonist	T103	UMLS:C2987634
28390176	1293	1302	inhibitor	T103	UMLS:C0243077
28390176	1307	1316	autophagy	T038	UMLS:C0004391
28390176	1317	1326	inhibitor	T103	UMLS:C0243077
28390176	1341	1355	overexpression	T038	UMLS:C1514559
28390176	1381	1384	Akt	T103	UMLS:C0164786
28390176	1410	1424	Cucurbitacin B	T103	UMLS:C0056580
28390176	1449	1468	cardiac hypertrophy	T038	UMLS:C1383860
28390176	1472	1477	human	T204	UMLS:C0086418
28390176	1478	1497	cardiomyocytes AC16	T017	UMLS:C0225828
28390176	1539	1553	cucurbitacin B	T103	UMLS:C0056580
28390176	1571	1590	cardiac hypertrophy	T038	UMLS:C1383860
28390176	1614	1623	autophagy	T038	UMLS:C0004391
28390176	1633	1647	cardiomyocytes	T017	UMLS:C0225828
28390176	1678	1688	inhibition	T038	UMLS:C1519312
28390176	1692	1695	Akt	T103	UMLS:C0164786
28390176	1698	1702	mTOR	T103	UMLS:C1453984
28390176	1705	1711	FoxO3a	T103	UMLS:C1506134
28390176	1712	1723	signal axis	T038	UMLS:C0037080